Comparison of the effect of 20mg Vonoprazan,30mg,Lansoprazole and 20mg Famotidine on intragastric pH: A three-way crossover study
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Famotidine (Primary) ; Lansoprazole (Primary) ; Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Pharmacodynamics
- 14 Feb 2018 Status changed from active, no longer recruiting to completed.
- 27 Oct 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 26 May 2016 New trial record